NCT00360087 A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study Status TERMINATED Phase PHASE3
NCT00323297 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT00319111 Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Status COMPLETED Phase PHASE3
NCT00319033 Open-label Study With Bosentan in Interstitial Lung Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00319020 Bosentan in Children With Pulmonary Arterial Hypertension Extension Study Status COMPLETED Phase PHASE3
NCT00317486 Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology Status COMPLETED Phase PHASE4
NCT00313222 Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension Status COMPLETED Phase PHASE3
NCT00313196 Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) Status TERMINATED Phase PHASE3
NCT00310830 Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE3
NCT00303459 Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE4
NCT00302211 The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE3
NCT00260819 Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia Status COMPLETED Phase PHASE1
NCT00091715 Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II Status COMPLETED Phase PHASE3
NCT00071461 Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2/PHASE3
NCT00070590 Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma Status COMPLETED Phase PHASE2/PHASE3